This information is intended only for healthcare professionals resident in the United Kingdom


Prescribing Information (PI) for COMRINATY LP.8.1®▼(mRNA encoding LP.8.1) 30 micrograms/dose dispersion for injection in pre-filled syringe COVID-19 mRNA vaccine for use in the private market and COMIRNATY KP.2▼(cemivameran) 30 micrograms/dose dispersion for injection in pre-filled syringe COVID-19 mRNA Vaccine

​​​​​

Pfizer Ltd. accepts no responsibility for the content or services of the linked site other than the information relating to Pfizer medicines which it has provided or reviewed

United Kingdom

COMIRNATY KP.2 30 microgram/dose dispersion for injection in pre-filled syringe

COMIRNATY LP.8.1 (mRNA encoding LP.8.1) 30 microgram/dose dispersion for injection in pre-filled syringe COVID-19 mRNA Vaccine 

COMIRNATY KP.2 (cemivameran) 30 micrograms/dose dispersion for injection in pre-filled syringe COVID-19 mRNA Vaccine

PP-CMR-GBR-0942 I August 2025